A detailed history of Prudential Financial Inc transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 14,900 shares of RPTX stock, worth $23,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,900
Previous 47,200 68.43%
Holding current value
$23,244
Previous $46,000 56.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$0.9 - $1.49 $29,070 - $48,127
-32,300 Reduced 68.43%
14,900 $20,000
Q1 2025

May 13, 2025

BUY
$0.99 - $1.39 $28,908 - $40,588
29,200 Added 162.22%
47,200 $46,000
Q4 2024

Feb 11, 2025

BUY
$1.25 - $3.97 $2,000 - $6,352
1,600 Added 9.76%
18,000 $23,000
Q3 2024

Nov 13, 2024

BUY
$2.75 - $3.99 $7,700 - $11,172
2,800 Added 20.59%
16,400 $56,000
Q2 2024

Aug 13, 2024

BUY
$3.02 - $4.7 $41,072 - $63,920
13,600 New
13,600 $44,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $65.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.